Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Holders of 5% or more of CDTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cidara Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 13G | 6.38%2.01M shares | New | Jan 30, 20261 filing | Jan 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
60 Schedule 13D and 13G filings on Cidara Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 16, 2021 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Oct 14, 2021 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| Aug 12, 2021 | Interwest Partners X LP | 13D/AOld format | – | – | – | SEC |
| Mar 8, 2021 | Lytton Laurence W | 13G/AOld format | – | – | – | SEC |
| Mar 5, 2021 | Lytton Laurence W | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | 5AM Ventures III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Omega Fund V, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Stonepine Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cidara Therapeutics, Inc. shares.
No Form 144 notices for Cidara Therapeutics, Inc. are on file.